To change the game of ovarian cancer research - we have to go global!
OvaCure is pleased to announce our new non-profit US organisation status as a 501(c)3 tax exempt charity based on a letter of confirmation from the US Internal Revenue Service dated 18th July 2017. The OvaCure Foundation will function as our new US entity which will bridge our work across the pond. This status will help us accomplish our goals by engaging in new partnership building and US-based fundraising.
All US donations to the OvaCure Foundation are tax deductible and are 100% directed to our breakthrough, in-patient, clinical trial projects.